Skip to main content
Clinical Trials/NCT00977366
NCT00977366
Completed
Not Applicable

Pilot Study Investigating Central Sensitisation of the Cough Reflex in Subjects With Chronic Cough and Healthy Volunteers

University of Manchester1 site in 1 country27 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cough
Sponsor
University of Manchester
Enrollment
27
Locations
1
Primary Endpoint
Effect of oesophageal acid infusion on cough reflex sensitivity in chronic cough patients compared to healthy controls.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Central sensitisation is an increase in the excitability of nerves within the central nervous system, which can lead to heightened sensitivity to certain stimuli. This process is involved in some chronic pain conditions e.g. migraines and non-cardiac chest pain. Recent work by our group suggests central sensitisation may be an important mechanism leading to chronic cough.

The main questions in this study include:

  1. Can the investigators induce temporary central sensitisation of the cough reflex in healthy volunteers for testing of new medications?
  2. Can the investigators demonstrate exaggerated sensitisation in patients with chronic cough (indicating these patients are already centrally sensitised)?

In animal studies, acid infusion into the gullet (oesophagus) is able to induce central sensitisation of the cough reflex. Acid infusion into the oesophagus has also been shown to induce central sensitisation in human healthy volunteers, increasing the sensitivity to pain on the front of the chest but this study did not test the the cough reflex. Using human participants, the investigators plan to test whether acid infusion into the oesophagus increases the sensitivity of the cough reflex in healthy volunteers and also patients complaining of chronic cough.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
February 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jacky Smith

MRC Clinician Scientist/Honorary Respiratory Consultant

University of Manchester

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers inclusion:
  • Over 18 years
  • Measurable cough reflex sensitivity - required as is the primary end-point
  • No current or past history of chronic cough or chronic respiratory disease
  • Chronic Cough Patients inclusion:
  • Over 18 years
  • Chronic persistent cough (\> 8 weeks) despite investigation and/or treatment trials for cough variant asthma/post-nasal drip and gastro-oesophageal reflux
  • Normal chest radiograph - primary respiratory cause for cough excluded
  • Normal lung function - primary respiratory cause for cough excluded Measurable cough reflex sensitivity - required as primary end-point

Exclusion Criteria

  • Recent upper respiratory tract infection (\<4 weeks) - this can lead to increased sensitivity of the cough reflex which resolves as the infection settles
  • Pregnancy/breast-feeding - unknown effects of oesophageal acid infusion
  • Current smokers or ex-smokers with \< 6 month abstinence or history \> 20 pack years - smoking can alter the sensitivity of the cough reflex
  • Opiate or ACE inhibitor use or centrally acting medication - can alter the cough reflex sensitivity
  • Symptomatic gastro-oesophageal reflux, post-nasal drip or asthma (chronic cough cohort may have been treated for these in the past but cough did not resolve) - these conditions are known to cause cough and alter cough reflex sensitivity
  • Significant ongoing chronic respiratory/cardiovascular/gastro-intestinal/haematological/ neurological/psychiatric illness. We are aiming to recruit healthy volunteers and chronic cough patients who are otherwise healthy

Outcomes

Primary Outcomes

Effect of oesophageal acid infusion on cough reflex sensitivity in chronic cough patients compared to healthy controls.

Time Frame: baseline, immediatley after infusion, 90 minutes post infusion, 180 minutes post infusion, 24 hours after baseline

Outcome measures include; cough reflex sensitivity, pain threshold measures, 24 hour objective cough rate

Study Sites (1)

Loading locations...

Similar Trials